SynBioBeta 2026 Speaker

Ekaterine Kortkhonjia

J&J

Sr. Dir, Transactions

Eka Kortkhonjia, Ph.D., M.S., is a Senior Director of Transactions at Johnson & Johnson, where she leads strategic partnering efforts aimed at advancing transformative innovation across the companyโ€™s priority therapeutic areas. In her role, she is responsible for evaluating external scientific opportunities, overseeing due diligence, and structuring strategic transactions that support the companyโ€™s long term R&D and portfolio objectives.Eka also plays a key role in shaping the innovation ecosystem surrounding Johnson & Johnson. She supports the Johnson & Johnson Innovation โ€“ JJDC venture fund, working closely with early stage companies to accelerate breakthrough science. In addition, she collaborates with the global JLABS incubator network, helping nurture emerging biotech and technology platforms by providing strategic insights and fostering connections that enable growth.Prior to joining Johnson & Johnson, Eka spent more than 13 years at Genentech/Roche in roles of increasing responsibility across Pharma Partnering, Biomarker Development, and Investor Relations. Her experience spans end to end partnering strategy, biomarker and translational program leadership, and communication of scientific and business priorities to investors and external stakeholders. Throughout her career, Eka has built a strong track record of integrating science, strategy, and cross functional collaboration to support innovation from discovery to development.Before transitioning into industry leadership roles, Eka completed postdoctoral training at both the University of California, Los Angeles (UCLA) and Genentech. During this time, she conducted research at the intersection of biophysics, structural biology, and translational science, contributing to a deeper understanding of complex biological systems. Eka holds a Ph.D. in Chemistry and Chemical Biology and an M.S. in Biophysics.

Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure
Blue watercolor splatter with lime dots
Blue watercolor splatter
Speaker photo

Reagan

Jarvis

Anocca AB

CEO, Co-founder

Speaker photo

Alex

Rives

CZI Biohub

Head of Science

Speaker photo

Karenโ€ฏ

Akinsanya

Schrodinger

President, R&D โ€“ Therapeutics

Speaker photo

Christopher

Arendt

Takeda

CSO, Head of Research

Speaker photo

Stef

van Grieken

Cradle

CEO

Speaker photo

Michael

Koeris

DARPA

Director, BTO

Speaker photo

Jennifer

Dionne

Pumpkinseed

CEO

Speaker photo

Daniyal

Hussain

GSK

Exec. Dir., Tech BD

Speaker photo

Cynthia

Hong

Novartis

Dir., Search & Evaluation

Speaker photo

Sarah Lynn

Tao

CSL Behring

Sr. Dir., S&E; Ig TA & Tech Lead

Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure

SynBioBeta 2027 May 3-6, San Jose, California